Enhanced Sp1 DNA-binding activity in murine keratinocyte cell lines and epidermal tumors

A P Kumar1, A P Butler

  • 1Department of Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Smithville 78957, USA. kumar@odin.mdacc.tmc.edu

Cancer Letters
|June 22, 1999
PubMed

Insights

Transcription factor Sp1 activity increases with epidermal tumor progression. This enhanced Sp1 DNA binding may drive tumor cell proliferation by upregulating genes like ornithine decarboxylase (ODC).

Area of Science:

  • Molecular biology
  • Cancer research
  • Dermatology

Background:

  • Altered ornithine decarboxylase (ODC) regulation is common in epidermal tumors.
  • The transcription factor Sp1 activates ODC expression, while Sp3 antagonizes this.
  • Understanding Sp1 and Sp3 roles is crucial for epidermal tumor research.

Purpose of the Study:

  • To investigate the levels and DNA-binding activity of Sp1 and Sp3 in epidermal carcinogenesis.
  • To correlate Sp1 and Sp3 activity with tumor progression from papillomas to squamous cell carcinomas.

Main Methods:

  • Analysis of nuclear extracts from primary keratinocytes, transformed cell lines, and murine epidermal tumors.
  • Quantification of Sp1 and Sp3 levels and DNA-binding activity.

Main Results:

  • Sp1 DNA-binding activity was higher in established keratinocyte cell lines than in primary cells.
  • Sp1 levels and DNA-binding activity were low in papillomas but high in squamous cell carcinomas.
  • Sp3's role was not detailed in this abstract, focus is on Sp1.

Conclusions:

  • Increased Sp1 levels and DNA-binding activity correlate with epidermal tumor progression.
  • Enhanced Sp1 DNA binding may promote tumor cell proliferation via Sp1-responsive genes, potentially including ODC.